Skip to content
ELIOS Vision
  • How We Address Glaucoma
  • Our Clinical Data
  • About Us
  • How We Address Glaucoma
  • Our Clinical Data
  • About Us

ELIOS combined with cataract surgery delivers significant IOP reduction out to 8 years

Today, ELIOS Vision, Inc. announced the eight-year follow up results of its novel ELIOS® Excimer Laser Trabeculostomy procedure combined with cataract surgery.

Continue reading
Linkedin-in Twitter Facebook-f Instagram

Disclaimer

ELIOS Vision GmbH is the EU distributor of ELIOS manufactured by MLase AG, located at 82110 Germering, Industriestr. 17 and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.

Caution: Investigational device – Limited by Federal (or United States) law to investigational use. ELIOS is not currently approved for use in the U.S.

© ELIOS Vision, Inc. 2022. All rights reserved. ELIOS Vision and ELIOS are trademarks of ELIOS Vision, Inc.

  • Terms & Conditions
  • Privacy Policy
  • Terms & Conditions
  • Privacy Policy